CDIO
Cardio Diagnostics Holdings, Inc.
Next earnings Aug 12, 2026
$1.99
▼ -4.33%$1.99▼ -44.72%
over 1Y
L $1.05H $6.55
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-4.3%
1W-1.5%
1M-15.3%
3M-2.5%
YTD-29.9%
1Y-44.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.11x); but revenue fell -57.5% YoY.
Revenue (FY2025) $14.8K · FY2025
Cardio Diagnostics Holdings, Inc. shows $14.8K in FY2025 revenue (-57.5% YoY), a -43832.5% net margin, and -93.2% ROE.
Supporting the case: conservative balance sheet (liabilities/equity 0.11x).
Is CDIO a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread (caution)~60d expiry
- Long put 2 @ ~0.29 est
- Short put 2 @ ~0.29 est
debit $0max +$0max $0
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $901.00 | $950.00 | $17.1K | $34.9K | $14.8K |
| Gross profit | — | — | — | — | — |
| Operating income | -$620K | -$4.55M | -$7.24M | -$8.37M | -$6.48M |
| Net income | -$620K | -$4.66M | -$8.38M | -$8.38M | -$6.50M |
| Diluted EPS | -$0.53 | -$1.51 | -$0.66 | -$9.35 | -$3.71 |
| Net margin | -68862.2% | -490630.0% | -49087.8% | -24028.2% | -43832.5% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$5.89M
EV / EBITDA—
EV / Sales397.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-110.3%
FCF yield-100.4%
Quality & risk
ROIC (est.)-73.5%
Free cash flow-$5.91M
Total debt—
Net cash$0.00
Altman Z-Score-2.75 distress
Piotroski F-Score2/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-94.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗10-QPeriod ending 2026-03-312026-05-15open ↗4Period ending 2026-03-312026-04-02open ↗4Period ending 2026-03-312026-04-02open ↗4Period ending 2026-03-312026-04-02open ↗4Period ending 2026-03-312026-04-02open ↗10-KPeriod ending 2025-12-312026-03-13open ↗8-KPeriod ending 2026-02-192026-02-19open ↗4Period ending 2025-12-312026-01-06open ↗
Frequently asked
- Is Cardio Diagnostics Holdings, Inc. (CDIO) a buy?
- CDIO currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.11x); but revenue fell -57.5% YoY.
- What is Cardio Diagnostics Holdings, Inc.'s quality score?
- CDIO scores 37.49550699300699/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001870144, latest 10-Q filed 2026-05-15) · EODHD · as of 7/5/2026, 4:38:08 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 5, 2026, 12:38 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.